Internal Medicine, Nephrology · Toledo, OH
NPI
1134350523
Since 2009
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
2109 Hughes Dr Ste 920
Toledo, OH, 43606
Phone (304) 479-2650
Groups this clinician bills Medicare through
Medicare paid, 2024
$148K
1,752 services
Medicare patients, 2024
613
Average age 74
Drug cost, 2024
$645K
1,735 prescriptions
Company payments, 2025
$1,021
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohamed Amin Kadoura was code 99232 (hospital e&m - subsequent), 883 times for 361 patients. In total Mohamed Amin Kadoura billed 1,752 services in 22 codes, and Medicare paid $148K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 883 | 361 | $62.05 | $55K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 159 | 127 | $12.57 | $1,999 |
| 99223 Hospital E&M - Initial | Facility | 120 | 118 | $132.51 | $16K |
| 99214 Office E&M - Established | Office | 107 | 78 | $91.55 | $9,796 |
| 90960 ESRD Related Services (not dialysis) | Office | 101 | 15 | $278.66 | $28K |
| 99204 Office E&M - New | Office | 94 | 94 | $116.51 | $11K |
| 99222 Hospital E&M - Initial | Facility | 66 | 64 | $100.56 | $6,637 |
| 99233 Hospital E&M - Subsequent | Facility | 61 | 40 | $93.87 | $5,726 |
| 90945 Peritoneal Dialysis | Facility | 52 | 27 | $66.26 | $3,446 |
| 90961 ESRD Related Services (not dialysis) | Office | 25 | 13 | $231.43 | $5,786 |
| 90935 Hemodialysis | Facility | 15 | 12 | $55.72 | $836 |
By year: 2022 $172K for 1,927 services; 2023 $164K for 1,812 services; 2024 $148K for 1,752 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mohamed Amin Kadoura prescribed most often to Medicare patients was Bumetanide, with 157 prescriptions and refills. In total Mohamed Amin Kadoura wrote 1,735 Medicare prescriptions that cost $645K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Bumetanide Generic | 157 | 273 | 47 | $6,458 |
| Losartan Potassium Generic | 145 | 367 | 52 | $1,414 |
| Nifedipine Er Nifedipine | 141 | 281 | 43 | $3,897 |
| Farxiga Dapagliflozin Propanediol | 117 | 265 | 41 | $144K |
| Potassium Chloride Generic | 105 | 175 | 33 | $2,002 |
| Carvedilol Generic | 94 | 222 | 35 | $1,122 |
| Calcitriol Generic | 82 | 230 | 34 | $1,008 |
| Sevelamer Carbonate Generic | 65 | 134 | 22 | $18K |
| Valsartan Generic | 59 | 117 | 20 | $1,082 |
| Jardiance Empagliflozin | 57 | 121 | 17 | $71K |
| Lisinopril Generic | 50 | 142 | 23 | $477 |
| Furosemide Generic | 46 | 88 | 14 | $175 |
| Spironolactone Generic | 43 | 101 | 15 | $415 |
| Terazosin Hcl Generic | 42 | 73 | 11 | $489 |
| Famotidine Generic | 40 | 67 | 12 | $420 |
Brand drugs: 313 claims; generic drugs: 1,422 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohamed Amin Kadoura $1,021 ($1,021 in general payments such as food, travel and fees) from 12 companies. The largest payer was Travere Therapeutics, Inc. with $201.
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. TVTX | 9 | $201 |
| Amgen Inc. AMGN | 9 | $155 |
| Calliditas Therapeutics US Inc. | 4 | $126 |
| Akebia Therapeutics Inc AKBA | 5 | $112 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $104 |
| Ardelyx, Inc. ARDX | 4 | $83.19 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $75.4 |
| Mallinckrodt Hospital Products Inc. | 2 | $39.54 |
| Apellis Pharmaceuticals, Inc. APLS | 2 | $37.27 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $34.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.